ClariVest Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-66,968
| Closed | -$290K | – | 959 |
|
|
2023
Q3 | $290K | Hold |
66,968
| – | – | 0.02% | 366 |
|
|
2023
Q2 | $442K | Buy |
66,968
+24,481
| +58% | +$162K | 0.02% | 356 |
|
|
2023
Q1 | $288K | Sell |
42,487
-13
| -0% | -$88 | 0.01% | 413 |
|
|
2022
Q4 | $314K | Sell |
42,500
-700
| -2% | -$5.17K | 0.02% | 412 |
|
|
2022
Q3 | $427K | Buy |
43,200
+13,800
| +47% | +$136K | 0.02% | 380 |
|
|
2022
Q2 | $320K | Hold |
29,400
| – | – | 0.01% | 425 |
|
|
2022
Q1 | $332K | Sell |
29,400
-4,037
| -12% | -$45.6K | 0.01% | 432 |
|
|
2021
Q4 | $525K | Sell |
33,437
-600
| -2% | -$9.42K | 0.02% | 428 |
|
|
2021
Q3 | $584K | Sell |
34,037
-100
| -0.3% | -$1.72K | 0.02% | 417 |
|
|
2021
Q2 | $735K | Hold |
34,137
| – | – | 0.02% | 357 |
|
|
2021
Q1 | $513K | Sell |
34,137
-27,555
| -45% | -$414K | 0.02% | 409 |
|
|
2020
Q4 | $809K | Sell |
61,692
-40,773
| -40% | -$535K | 0.03% | 299 |
|
|
2020
Q3 | $990K | Sell |
102,465
-42,193
| -29% | -$408K | 0.03% | 302 |
|
|
2020
Q2 | $1.66M | Sell |
144,658
-847
| -0.6% | -$9.69K | 0.05% | 260 |
|
|
2020
Q1 | $1.51M | Buy |
145,505
+27,040
| +23% | +$280K | 0.05% | 235 |
|
|
2019
Q4 | $1.94M | Sell |
118,465
-27,965
| -19% | -$459K | 0.04% | 251 |
|
|
2019
Q3 | $1.95M | Buy |
146,430
+32,800
| +29% | +$436K | 0.04% | 260 |
|
|
2019
Q2 | $1.6M | Sell |
113,630
-1,017
| -0.9% | -$14.3K | 0.04% | 271 |
|
|
2019
Q1 | $2.11M | Buy |
114,647
+75,519
| +193% | +$1.39M | 0.04% | 305 |
|
|
2018
Q4 | $1.02M | Sell |
39,128
-1,550
| -4% | -$40.5K | 0.02% | 391 |
|
|
2018
Q3 | $933K | Hold |
40,678
| – | – | 0.02% | 431 |
|
|
2018
Q2 | $775K | Sell |
40,678
-5,900
| -13% | -$112K | 0.01% | 473 |
|
|
2018
Q1 | $784K | Buy |
46,578
+579
| +1% | +$9.75K | 0.01% | 455 |
|
|
2017
Q4 | $698K | Buy |
45,999
+40,000
| +667% | +$607K | 0.01% | 459 |
|
|
2017
Q3 | $107K | Buy |
5,999
+232
| +4% | +$4.14K | ﹤0.01% | 536 |
|
|
2017
Q2 | $94K | Hold |
5,767
| – | – | ﹤0.01% | 551 |
|
|
2017
Q1 | $81K | Buy |
+5,767
| New | +$81K | ﹤0.01% | 575 |
|